Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

InCommon, a division of CadentInCommon, a division of Cadent
VS
NovartisNovartis
InCommon, a division of Cadent

InCommon, a division of Cadent

New York, US

Last Update: 24/12/2025

View Profile
Between 750 and 799
https://www.incommon.info/
753/1000Fair

InCommon is a results-oriented team designed to empower patient communities through meaningful alliances between Industry and Advocacy. We are a new division created by leaders in health education, with deep roots in Advocacy and Healthcare. We leverage the vast resourc...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:None
Subsidiaries:14
12-month incidents
0
Known data breaches
0
Attack type number
0
Novartis

Novartis

Novartis Campus, Basel, 4002, CH

Last Update: 20/05/2026

View Profile
Between 800 and 849
http://www.novartis.com
809/1000Good

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million pe...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:82,910
Subsidiaries:32
12-month incidents
1
Known data breaches
1
Attack type number
2

Compliance Ranges Comparison

Based On Specific Ai Models Category
InCommon, a division of Cadent

InCommon, a division of Cadent

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Novartis

Novartis

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for InCommon, a division of Cadent in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Novartis has 3.85% fewer incidents than the average of all companies with at least one recorded incident.

Incidents

Incident History - InCommon, a division of Cadent (X = Date, Y = Severity)

InCommon, a division of Cadent cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Novartis (X = Date, Y = Severity)

Novartis cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
InCommon, a division of Cadent

InCommon, a division of Cadent

Incidents
No explicit notable incidents reported.
Novartis

Novartis

Incidents
🔒 Incident : Breach
NOV1774449180
🔒 Incident : Cyber Attack
NOV21267722

FAQ

Between InCommon, a division of Cadent company and Novartis company, which one has the best AI Cybersecurity Score ?
Between InCommon, a division of Cadent company and Novartis company, which one has experienced more cyber incidents in the past ?
Between InCommon, a division of Cadent company and Novartis company, which one has experienced more cyber incidents this year ?
Between InCommon, a division of Cadent company and Novartis company, which one has experienced at least one ransomware attack ?
Between InCommon, a division of Cadent company and Novartis company, which one has experienced at least one data breach ?
Between InCommon, a division of Cadent company and Novartis company, which one has experienced at least one targeted cyberattack ?
Between InCommon, a division of Cadent company and Novartis company, which one has experienced at least one vulnerability ?
Between InCommon, a division of Cadent company and Novartis company, which one holds the most compliance certifications ?
Between InCommon, a division of Cadent company and Novartis company, which one holds the fewest compliance certifications ?
Between InCommon, a division of Cadent company and Novartis company, which one has the most subsidiaries ?
Between InCommon, a division of Cadent company and Novartis company, which one has the largest number of employees ?
Between InCommon, a division of Cadent and Novartis, which company holds both SOC 2 Type 1 certifications ?
Between InCommon, a division of Cadent and Novartis, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - InCommon, a division of Cadent or Novartis ?
Which company is PCI DSS compliant - InCommon, a division of Cadent or Novartis ?
Between InCommon, a division of Cadent and Novartis, which company complies with HIPAA regulations for healthcare data ?
Between InCommon, a division of Cadent and Novartis, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-61246
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-60455
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-60439
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-60373
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-60372
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 9.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 9.8)
CVSS3
Base Score: 9.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
3.9